THERAPEUTIC ANTIBODIES

ANTIBODIES AGAINST TIM3 AND USES THEREOF

ANTI-CNTN4-SPECIFIC ANTIBODIES AND USE THEREOF

MULTITARGETING BISPECIFIC ANTIGEN-BINDING MOLECULES OF INCREASED SELECTIVITY

USE OF IL-6 ANTIBODIES AND VEGF TRAPS, AND FUSION CONSTRUCTS AND CONJUGATES THEREOF

METHODS OF TREATING ALLERGY USING ANTI-BET V 1 ANTIBODIES

Method of Reducing Blood Glucose Levels and Inhibiting Secreted aP2

DOSAGE AND ADMINISTRATION OF ANTI-C5 ANTIBODIES FOR TREATING HEMATOPOIETIC STEM CELL TRANSPLANT-ASSOCIATED THROMBOTIC MICROANGIOPATHY (HSCT-TMA)

Composition for the treatment of antibody deficiencies

MUCOSAL EXPRESSION OF ANTIBODY STRUCTURES AND ISOTYPES BY MRNA

NEUTRALIZING ANTI-INFLUENZA A ANTIBODIES AND USES THEREOF

LINKERS, DRUG LINKERS AND CONJUGATES THEREOF AND METHODS OF USING THE SAME

COMPOSITIONS AND METHODS FOR THE DEPLETION OF CELLS

CORONAVIRUS ANTIBODY

PD-L1-BINDING MOLECULES COMPRISING SHIGA TOXIN A SUBUNIT SCAFFOLDS

TREATMENT OF LUPUS USING HUMANIZED ANTI-CXCR5 ANTIBODIES

CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS

TUMOR INFILTRATING LYMPHOCYTES THERAPY

Combination Therapies Comprising C/EBP Alpha saRNA

FLUOROCARBON COMPOSITIONS AND METHODS FOR ENHANCING IMMUNOTHERAPY

ANIMAL MODELS AND THERAPEUTIC MOLECULES

METHODS AND SYSTEMS FOR THERAPY MONITORING AND TRIAL DESIGN

IMMUNOMODULATING TRANSGENIC PLANTS AND RELATED METHODS

TREATMENT OF AUTOIMMUNE DISEASE

METHOD FOR ALLOWING IMMUNE CELLS INFILTRATION IN TUMORS

CD73 (NT5E) TARGETING POLYPEPTIDES

Applications of GHR-106 Monoclonal Antibody as a GnRH Antagonist

TREATMENT OF OPHTHALMIC DISEASES

METHODS FOR TREATING OR PREVENTING ASTHMA BY ADMINISTERING AN IL-4R ANTAGONIST

MULTISPECIFIC PROTEINS COMPRISING AN NKP46-BINDING SITE, A CANCER ANTGIENGE BINDING SITE FUSED TO A CYTOKINE FOR NK CELL ENGAGING

Pharmaceutical Composition

COMBINATION THERAPIES WITH BISPECIFIC ANTI-EGFR/C-MET ANTIBODIES AND THIRD GENERATION EGFR TYROSINE KINASE INHIBITORS

ANTI-EGFR ANTIBODY DRUG CONJUGATES

COMPOSITIONS AND METHODS FOR TREATING CHRONIC ACTIVE WHITE MATTER LESIONS / RADIOLOGICALLY ISOLATED SYNDROME

METHODS FOR TREATING CANCER

CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS

GP130 Binding Molecules and Methods of Use

Method of Treating Ulcerative Colitis with Anti-IL23 Specific Antibody

Anti-IL-23 Antibodies

Anti-IL-27 Antibodies and Uses Thereof

IL-17A BINDING PROTEINS

THERAPEUTIC AND DIAGNOSTIC AGENTS AND USES THEREOF

HYPERIMMUNIZED EGG PRODUCT FOR TREATING OR PREVENTING ALCOHOLIC LIVER DISEASE AND GRAFT-VERSUS-HOST DISEASE

T-cell modulatory multimeric polypeptides and methods of use thereof

IMMUNOMODULATORY COMPLEX AND USES THEREOF FOR THERAPY

TNF-ALPHA IMMUNOCONJUGATE THERAPY FOR THE TREATMENT OF BRAIN TUMORS

COMPOSITIONS AND METHODS FOR TARGETED TUMOR IMMUNOTHERAPY

METHODS FOR TREATING PATIENTS WITH REFRACTORY HYPERCHOLESTEROLEMIA

TREATMENT OF PEANUT ALLERGY WITH TOLERIZING NANOPARTICLES

METHODS OF TREATMENT AND DOSING OF NATURAL KILLER CELL COMPOSITIONS

TREATMENT OF CANCER WITH NK CELLS AND A HER2 TARGETED ANTIBODY

DITERPENOID COMPOUNDS THAT ACT ON PROTEIN KINASE C (PKC)

Compounds and Methods for Use in Detecting Gabapentin

BIOMARKERS OF AGING FOR DETECTION AND TREATMENT OF DISORDERS

VACCINE FOR IMMUNOCOMPROMISED HOSTS

HIGH CONCENTRATION ANTIBODY FORMULATIONS

COMPOSITIONS AND METHODS FOR DELIVERY OF NUCLEIC ACIDS TO CELLS

FACTOR XI CATALYTIC DOMAIN-BINDING ANTIBODIES AND METHODS OF USE THEREOF

ANTIBODY AGAINST PANCREATIC CANCER STEM CELLS

COMBINATION THERAPY WITH AN ANTI-CA19-9 ANTIBODY AND FOLFIRINOX IN THE TREATMENT OF CANCER

ANTI-CEA ANTIBODIES AND METHODS OF USE

ANTI-CEA AND ANTI-CD137 MULTISPECIFIC ANTIBODIES AND METHODS OF USE

THERAPEUTIC CD99 ANTIBODIES

METHODS OF TREATING MULTIPLE MYELOMA

Novel TNFR2 Binding Molecules

COMBINATION THERAPIES COMPRISING AN ANTI-GITR ANTIBODY FOR TREATING CANCERS

Humanized Anti-CD70 Binding Agents and Uses Thereof

ANTI-HUMAN INTERLEUKIN-4 RECEPTOR ALPHA ANTIBODY AND PREPARATION METHOD AND APPLICATION THEREOF

IL-1 receptor accessory protein-inhibiting antibodies and antigen-binding fragments thereof

ANTI-ACVR1 ANTIBODIES AND USES THEREOF

ANTI-FGFR2 ANTIBODIES AND METHODS OF USE THEREOF

Anti-Axl Antagonistic Antibodies

USE OF an anti-P-selectin antibody

ANTI-GALECTIN-9 ANTIBODIES AND THERAPEUTIC USES THEREOF

SPECIFIC BINDING MOLECULES

THERAPEUTIC AND DIAGNOSTIC METHODS FOR CANCER

CONJUGATES COMPRISING CELL-BINDING AGENTS AND CYTOTOXIC AGENTS

COMPOSITION COMPRISING AN IGE ANTIBODY

IL-18 Binding Protein (IL-18BP) and Antibodies for Treating Inflammatory Diseases

METHOD OF TREATING DISEASES USING GREMLIN1 ANTAGONISTS

Compositions and methods comprising SFRP2 antagonists

ANTI-DENGUE VIRUS ANTIBODIES HAVING CROSS-REACTIVITY TO ZIKA VIRUS AND METHODS OF USE

CRYSTALLINE FORM OF A SHP2 INHIBITOR

COMBINATION CANCER THERAPY

DNA Monoclonal Antibodies Targeting Checkpoint Molecules

COMPOSITIONS AND METHODS FOR TREATING PEDIATRIC MYASTHENIA GRAVIS

HUMANIZED BCMA ANTIBODY AND BCMA-CAR-T CELLS

METHOD OF TREATMENT OF PATIENTS HAVING REDUCED SENSITIVITY TO A BCL-2 INHIBITOR

ANTIBODY AND USE THEREOF FOR THE TREATMENT OF CANCER

Site-Specific Modification of Glycoproteins Through Transglutaminase-Mediated Conjugation

THERAPEUTIC INHIBITORS OF GDF15 SIGNALLING

COMBINATION OF ANTI-GALECTIN-9 ANTIBODIES AND CHEMOTHERAPEUTICS FOR USE IN CANCER THERAPY

METHODS FOR THE TREATMENT OF CHRONIC POUCHITIS

ANTI-PD-1 ANTIBODIES AND USES THEREOF

HETERODIMERIC ANTIBODIES AND ANTIGEN-BINDING FRAGMENT THEREOF

Antibodies to programmed cell death protein 1 that are PD-1 agonists

STABLE FORMULATIONS OF ANTI-TIGIT ANTIBODIES ALONE AND IN COMBINATION WITH PROGRAMMED DEATH RECEPTOR 1 (PD-1) ANTIBODIES AND METHODS OF USE THEREOF

SCAFFOLD FOR BIFUNCTIONAL MOLECULES COMPRISING PD-1 OR CD28 AND SIRP BINDING DOMAINS

ANTIBODIES TO TIGIT

Reducing Systemic Regulatory T Cell Levels or Activity for Treatment of Disease and Injury of the CNS

CD33 SPECIFIC CHIMERIC ANTIGEN RECEPTORS FOR CANCER IMMUNOTHERAPY

TREATING CANCER BY BLOCKING THE INTERACTION OF TIM-3 AND ITS LIGAND

MODIFIED ANTI-TSLP ANTIBODIES

Safe and Effective Method of Treating Ulcerative Colitis with Anti-IL12/IL23 Antibody

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING IMMUNE DYSREGULATION-RELATED DISEASES COMPRISING OXIDIZED IMMUNOGLOBULIN AS ACTIVE INGREDIENT

CROSS-REACTIVE MONOCLONAL ANTIBODIES AGAINST CORONAVIRUSES

POLYPEPTIDES TARGETING DR4 AND/OR DR5 AND RELATED COMPOSITIONS AND METHODS

PH LOW INSERTION PEPTIDE AND COMPOSITION THEREOF

COMPOSITIONS AND METHODS FOR DELIVERING THERAPEUTIC POLYNUCLEOTIDES

ANTI-NECTIN-4 ANTIBODY AMANITIN CONJUGATES

CHIMERIC ANTIGEN RECEPTOR (CAR)-T CELLS

VACCINES AND IMMUNOGLOBULINS TARGETING AFRICAN SWINE FEVER VIRUS, METHODS OF PREPARING SAME, AND METHODS OF USING SAME

MICROORGANISMS PROGRAMMED TO PRODUCE IMMUNE MODULATORS AND ANTI-CANCER THERAPEUTICS IN TUMOR CELLS

CANCER THERAPY USING TOLL-LIKE RECEPTOR AGONISTS

THERAPY FOR METASTATIC UROTHELIAL CANCER WITH THE ANTIBODY-DRUG CONJUGATE, SACITUZUMAB GOVITECAN (IMMU-132)

C5AR1 INHIBITORS FOR TREATING HYPERSENSITIVITY REACTIONS TO TAXANES

Treatment of Parkinson's Disease

METHODS FOR THE DIAGNOSIS AND TREATMENT OF T CELL-LYMPHOMAS

THERAPEUTIC AND DIAGNOSTIC METHODS FOR MAST CELL-MEDIATED INFLAMMATORY DISEASES

Adenovirus armed with bispecific T cell activator

ANTI-C5 ANTIBODY/C5 IRNA CO-FORMULATIONS AND COMBINATION THERAPIES

METHODS, COMPOSITIONS AND USES FOR TARGETING SEMA7A IN THE DIAGNOSIS AND TREATMENT OF HEALTH CONDITIONS

BISPECIFIC ANTIBODIES AGAINST CD3 AND CD20 FOR TREATING RICHTER'S SYNDROME

MULTISPECIFIC BINDING AGENTS AGAINST CD40 AND CD137 IN THERAPY

THERAPEUTIC BINDING MOLECULES

CD131 BINDING PROTEINS AND USES THEREOF

ANTIBODIES THAT BIND EGFR AND CMET

FUSION PROTEINS, PHARMACEUTICAL COMPOSITIONS, AND THERAPEUTIC APPLICATIONS

ANTI-CD47 ANTIBODIES AND USES THEREOF

METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3

T CELL REGULATION

ANTI-TMEM106B ANTIBODIES AND METHODS OF USE THEREOF

Antibody Constructs for CLDN18.2 and CD3

METHODS OF TREATMENT USING PROTEIN BINDERS TO IRHOM2 EPITOPES

INTERFERON BETA ANTIBODIES AND USES THEREOF

IL-38-SPECIFIC ANTIBODIES

ANTI-CGRP COMPOSITIONS AND USE THEREOF

PARVOVIRUS ANTIBODY

GLYPICAN 3 ANTIBODIES AND CONJUGATES THEREOF

HUMAN CD33 ANTIBODIES AND GLUCOCORTICOID CONJUGATES

Pharmaceutical compositions comprising anti-human TSLP receptor antibodies and methods of using the same

PREDICTING OUTCOME OF TREATMENT WITH AN ANTl-alpha4beta7 INTEGRIN ANTIBODY

USE OF THERAPEUTIC COMPOSITIONS FOR THE TREATMENT OF PATIENTS WITH TUMORS OF EPITHELIAL ORIGIN

THERAPEUTIC COMBINATION FOR TREATING CANCER

TREM-1 INHIBITORS FOR THE TREATMENT OF MARFAN SYNDROME

COMPOSITIONS AND METHODS FOR INHIBITION OF CELL-PENETRATING ANTIBODIES

HUMANIZED ANTIBODIES AGAINST IRHOM2

HER2/4-1BB BISPECIFIC FUSION PROTEINS FOR THE TREATMENT OF CANCER

METHODS AND COMPOSITIONS RELATED TO ANTIBODY FRAGMENTS THAT BIND TO TUMOR-ASSOCIATED GLYCOPROTEIN 72 (TAG-72)

METHODS OF TREATING CANCER WITH NONFUCOSYLATED ANTI-CD70 ANTIBODIES

Anti-CXCR2 Antibodies and Uses Thereof

IL12RB1-BINDING MOLECULES AND METHODS OF USE

MULTI-SPECIFIC BINDING PROTEINS THAT BIND NKG2D, CD16, AND A TUMOR-ASSOCIATED ANTIGEN FOR ACTIVATION OF NATURAL KILLER CELLS AND THERAPEUTIC USES THEREOF TO TREAT CANCER

GLYCOENGINEERED Fc VARIANT POLYPEPTIDES WITH ENHANCED EFFECTOR FUNCTION

DOSAGE REGIMEN OF MAdCAM-1 ANTIBODY FOR TREATMENT OF NON-ALCOHOLIC STEATOHEPATITIS

NON-PLATELET DEPLETING AND NON-RED BLOOD CELL DEPLETING CD47 ANTIBODIES AND METHODS OF USE THEREOF

ANTI-LAG3 ANTIBODIES AND USES THEREOF

BINDING AGENTS TARGETING TUMORS AND/OR IMMUNE CELLS

MSLN AND CD3 BINDING AGENTS AND METHODS OF USE THEREOF

Anti-TSPAN8/anti-CD3 bispecific antibody and anti-TSPAN8 antibody

PHARMACEUTICAL USE OF FAM19A5 INVOLVED IN REGULATING GLIOGENESIS

Anti-GDF-15 antibodies

A-FABP NEUTRALIZING MONOCLONAL ANTIBODY AND PREPARATION METHOD AND USE THEREOF

MONOCLONAL ANTIBODY AND USES THEREOF FOR THE TREATMENT AND DIAGNOSIS OF MULTIDRUG-RESISTANT PATHOGENIC BACTERIAL INFECTIONS

ANTIGEN BINDING PROTEINS

ANTI-VARICELLA-ZOSTER VIRUS ANTIBODY AND USE THEREOF

ANTICANCER THERAPIES USING ANTI-CCR8 ANTIBODY, CHEMO AND IMMUNOTHERAPY COMBINATIONS

COMBINATION TREATMENT OF CD38-EXPRESSING TUMORS

NOVEL RECOMBINANT STRAIN OF MYCOBACTERIUM SMEGMATIS AND USE OF SAME

STABLE ANTIBODY-DRUG CONJUGATE, PREPARATION METHOD THEREFOR, AND USE THEREOF

Pharmaceutical Combinations for Treating Cancer

METHODS FOR ACTIVATION AND EXPANSION OF NATURAL KILLER CELLS AND COMBINATIONS WITH BISPECIFIC ANTIBODIES

METHODS FOR TREATING NEUROBLASTOMA

PROTONATED pH RESPONSIVE POLYMER ENCAPSULATION OF BISPECIFIC ANTIBODIES AND CYTOKINES

BIOMARKERS FOR IDENTIFYING AND TREATING CANCER PATIENTS

ANTIBODY THAT BINDS ERBB-2 AND ERBB-3

ANTIBODY THAT BINDS ERBB-2 AND ERBB-3

PREPARATIONS AND METHODS FOR TREATING A GD2 POSITIVE CANCER

ANTI-CD45-BASED CONDITIONING METHODS AND USES THEREOF IN CONJUNCTION WITH GENE-EDITED CELL-BASED THERAPIES

ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR RECEPTOR (GITR) AND USES THEREOF

ANTI-CD40 ANTIBODIES AND METHODS OF USE

Methods of Treating Ulcerative Colitis with Anti-LIGHT Antibodies

DNA-ENCODED BISPECIFIC ANTIBODIES TARGETING IL13Ra2 AND METHODS OF USE IN CANCER THERAPEUTICS

SUBCUTANEOUSLY ADMINISTERED ANTI-IL-6 RECEPTOR ANTIBODY

TREATMENT OF CARDIOMETABOLIC DISEASE WITH INHIBITORS OF TYPE I INTERFERON SIGNALLING

PHARMACEUTICAL COMPOSITION FOR TREATMENT OR PREVENTION OF MYASTHENIA GRAVIS

ANTI-HUMAN CXCR5 ANTIBODY AND USES THEREOF

METHODS FOR THE TREATMENT OF THYROID EYE DISEASE

ANTI-FGFR3 ANTIBODIES AND ANTIGEN-BINDING FRAGMENTS AND METHODS OF USE THEREOF

Humanized mAb107

FcRn Antibodies and Methods of Use Thereof

B7-H3 ANTIBODY OR ANTIGEN-BINDING FRAGMENT THEREOF, AND USE THEREOF

BIFUNCTIONAL MOLECULE BINDING TO HUMAN TGFß AND PD-L1, AND USE THEREOF

ANTI-ICOS ANTIBODIES

BISPECIFIC TRIVALENT ANTIBODIES BINDING TO CLAUDIN6 OR CLAUDIN18.2 AND CD3 FOR TREATMENT OF CLAUDIN EXPRESSING CANCER DISEASES

USES OF CD79B ANTIBODIES FOR AUTOIMMUNE THERAPEUTIC APPLICATIONS

BISPECIFIC ANTIGEN BINDING MOLECULES THAT BIND LEPTIN RECEPTOR AND/OR GP130, AND METHODS OF USE THEREOF

MULTIFUNCTIONAL BTLA EXTRACELLULAR DOMAIN CO-INHIBITORY MOIETY TRAPS TO MODULATE IMMUNE TOLERANCE

Antibody Agents Directed Against Lymphocyte Activation Gene-3 (LAG-3) and Uses Thereof

IL-6 BINDING MOLECULES

IMMUNE-STIMULATING IL-2 FUSION PROTEINS

GOUT FLARE PREVENTION METHODS USING IL-1BETA BLOCKERS

METHODS FOR TREATING CHOROIDAL NEOVASCULARIZATION USING ANTI-ANG2 X VEGF MULTI-SPECIFIC ANTIBODIES

WOUND HEALING ENHANCEMENT WITH ANTI-CERAMIDE ANTIBODIES

ANTI-N3pGlu AMYLOID BETA ANTIBODIES AND USES THEREOF

SH3YL1 Antibodies, Compositions Comprising the Same, and Vectors and Uses Thereof

HUMANIZED ANTI-LIV1 ANTIBODIES FOR THE TREATMENT OF CANCER

Antagonist Antibodies Directed Against Calcitonin Gene-Related Peptide and Methods Using Same

SARS-CoV-2 Antibodies and Fragments, Therapeutic Uses, Diagnostic Uses, and Compositions Related Thereto

ANTIBODY AGAINST SARS-COV-2

SYSTEMS AND METHODS FOR EXPRESSING BIOMOLECULES IN A SUBJECT

HUMAN IMMUNODEFICIENCY VIRUS (HIV) ANTIGENS AND EPITOPES AND PROTEINS THAT BIND THERETO

HUMAN APPLICATION OF ENGINEERED CHIMERIC ANTIGEN RECEPTOR (CAR) T-CELLS

LUNG-CANCER SPECIFIC T CELL DYSFUNCTION

COMPOSITIONS AND METHODS FOR CANCER THERAPY

USE OF sEphB4-HSA FUSION PROTEIN AS A FIRST-LINE THERAPY IN CANCER TREATMENT

STABLE ANTIBODY-DRUG CONJUGATE, PREPARATION METHOD THEREFOR, AND USE THEREOF

VIRAL VECTOR-DERIVED TARGET PROTEIN FOR ANTICANCER THERAPY AND BINDING MOLECULE OR FRAGMENT THEREOF SPECIFICALLY BINDING THERETO

SEQUENTIAL ANTI-CD19 THERAPY

TREATMENTS FOR PAIN

Chimeric Antigen Receptors and Methods of Use

ACTIVATABLE ANTIBODIES AND METHODS OF MAKING AND USING THEREOF

ANTI-KIT ANTIBODIES AND USES THEREOF

ANTIBODIES, ACTIVATABLE ANTIBODIES, BISPECIFIC ANTIBODIES, AND BISPECIFIC ACTIVATABLE ANTIBODIES AND METHODS OF USE THEREOF

Antibody Molecules to C5AR1 and Uses Thereof

REGIMENS AND METHODS OF TREATING MULTIPLE SCLEROSIS USING OFATUMUMAB

BISPECIFIC POLYPEPTIDES FOR ENGAGEMENT OF CAR EXPRESSING IMMUNE CELLS WITH ANTIGEN PRESENTING CELLS AND USES THEREOF

MESOTHELIN-TARGETED CD40 AGONISTIC MULTISPECIFIC ANTIBODY CONSTRUCTS FOR THE TREATMENT OF SOLID TUMORS

BINDING MOLECULES FOR THE TREATMENT OF CANCER

COMPOSITION FOR TREATING IL-6-RELATED DISEASES

ANTI-ACVRI ANTIBODIES AND THEIR USE IN THE TREATMENT OF TRAUMA-INDUCED HETEROTOPIC OSSIFICATION

MODULATION OF WNT SIGNALING IN GASTROINTESTINAL DISORDERS

LYM-1 AND LYM-2 ANTIBODY COMPOSITIONS AND IMPROVED CAR CONSTRUCTS

ANTI-B7-H1 ANTIBODIES FOR TREATING TUMORS

COMPOSITIONS AND METHODS FOR TREATING CANCER WITH SUBCUTANEOUS ADMINISTRATION OF ANTI-PD1 ANTIBODIES

ANTI-IGFBP7 CONSTRUCTS AND USES THEREOF

LILRB1 AND LILRB2-BINDING MOLECULES AND USES THEREFOR

ANTI-CD47 AGENT-BASED OVARIAN CANCER THERAPY

Anti-LAG-3 Antibodies to Treat Hematological Malignancies

ANTI-TNF ANTIBODIES, COMPOSITIONS, AND METHODS FOR THE TREATMENT OF ACTIVE ANKYLOSING SPONDYLITIS

ANTI-TAU ANTIBODIES AND USES THEREOF

ANTIBODIES AGAINST TDP-43 AND METHODS OF USING THE SAME

COMPOSITIONS AND METHODS FOR INCREASING TRANSPORT INTO THE BRAIN

ANTIVIRALS AGAINST MEASLES VIRUS

DNA Monoclonal Antibodies Targeting Influenza Virus

Anti-coronavirus antibodies and methods of use

NOVEL HUMAN INTERLEUKIN-18 VARIANT AND USE THEREOF

MATRIPTASE AND U-PLASMINOGEN ACTIVATOR SUBSTRATES AND OTHER CLEAVABLE MOIETIES AND METHODS OF USE THEREOF

BISPECIFIC NANOPARTICLE SYSTEMS FOR TARGETING CANCER CELLS

METHODS OF TREATING AN OCULAR DISEASE OR DISORDER

CANCER VACCINE AND METHOD OF USE THEREOF

Synergistic Inhibition of eIF5A and Notch Signaling

COMBINATION OF AN AHR INHIBITOR WITH A PDX INHIBITOR OR DOXORUBICINE

COMBINATIONS FOR TREATMENT OF CANCERS RESISTANT TO EGFR-TARGETED THERAPIES

METHODS AND COMPOSITIONS FOR NEOADJUVANT AND ADJUVANT UROTHELIAL CARCINOMA THERAPY

DLL3 BINDING PROTEINS AND METHODS OF USE

ANTIBODIES THAT BIND CD123 AND GAMMA-DELTA T CELL RECEPTORS

ACTIVATION OF (NA++K+)-ATPASE INHIBITS PLATELET AGGREGATION AND PREVENTS THROMBOSIS

Administration of Anti-HPA-1a Antibodies

ANTI-MET ANTIBODIES AND USES THEREOF

ANTI-KIT ANTIBODIES AND USES THEREOF

ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS

METHODS AND COMPOSITIONS FOR ACTIVATION OF T CELLS USING NANOPARTICLES CONJUGATED WITH MULTIPLE LIGANDS FOR BINDING RECEPTORS ON T CELLS

Human Anti-CD27 Antibodies

ANTIBODIES AGAINST TL1A AND USES THEREOF

ANTI-CCR8 MONOCLONAL ANTIBODIES AND USES THEREOF

TREATMENTS FOR PRURIGO NODULARIS

Wnt surrogate molecules and uses thereof

ANTI-VISTA CONSTRUCTS AND USES THEREOF

ANTI-CTLA4 ANTIBODIES AND METHODS OF MAKING AND USING THE SAME

FUSION CONSTRUCTS AND METHODS OF USING THEREOF

BISPECIFIC ANTIBODY THAT BINDS TO CD3 AND A FLUOROPHORE

CHIMERIC ANTIGEN RECEPTORS (CARs), COMPOSITIONS AND METHODS THEREOF

ANTI-TIGIT AND ANTI-CD96 ANTIBODIES

ANTI-HUMAN VISTA ANTIBODIES AND USE THEREOF

Anti-Il-22 Antibodies, Antibody Fragments,Their Immunoconjugates And Uses Thereof

COMPOUNDS AND METHODS TARGETING INTERLEUKIN-34

Methods of Treating Crohn's Disease with Anti-IL23 Specific Antibody

VEGF-BINDING MOLECULES

Antibodies to PfGARP kill malaria parasites and protect against infection and severe disease

BISPECIFIC BINDING MOLECULE

USE OF A PERIOSTIN ANTIBODY FOR TREATING INFLAMMATION, FIBROSIS AND LUNG DISEASES

ANTI-TRANSTHYRETIN ANTIBODIES

ANTI-C5 ANTIBODIES HAVING IMPROVED PHARMACOKINETICS

METHODS OF TREATING CANCER USING DKK-1 INHIBITORS

T-cell modulatory multimeric polypeptides and methods of use thereof

CONSTRAINED CONDITIONALLY ACTIVATED BINDING PROTEINS

USE OF HIF-1-ALPHA INHIBITORS IN CANCER IMMUNOTHERAPY

WEEKLY DOSING REGIMENS FOR ANTI-CD30 VC-PAB-MMAE ANTIBODY DRUG-CONJUGATES

T-CELLS COMPRISING ANTI-CD38 AND ANTI-CD138 CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF

CELLS EXPRESSING MULTIPLE CHIMERIC ANTIGEN RECEPTOR (CAR) MOLECULES AND USES THEREFORE

COMBINATION THERAPY WITH A VINCA ALKALOID N-OXIDE AND AN IMMUNE CHECKPOINT INHIBITOR

BISPECIFIC SINGLE DOMAIN ANTIBODY TO PD-L1 AND CD47 AND USE THEREOF

ANTI-CHITINASE-3-LIKE PROTEIN-1 (YKL-40) NEUTRALIZING ANTIBODY AND USES THEREOF

ANTIBODIES AGAINST CD38 FOR TREATMENT OF MULTIPLE MYELOMA

CRTAM ANTIBODIES AND METHODS OF TREATING CANCER

ANTI-TRANSFERRIN RECEPTOR ANTIBODIES AND USES THEREOF

Compositions and methods of treating facioscapulohumeral muscular dystrophy

COMBINATION THERAPIES WITH ANTI CD40 ANTIBODIES

SILENT Fc VARIANTS OF ANTI-CD40 ANTIBODIES